We appreciate you taking the time to help America’s Health Rankings better understand our audiences. Your feedback will allow us to optimize our website and provide you with additional resources in the future. Thank you.
Explore national- and state-level data for hundreds of health, environmental and socioeconomic measures, including background information about each measure. Use features on this page to find measures; view subpopulations, trends and rankings; and download and share content.
United States Value:
Percentage of females ages 65-74 who reported receiving a mammogram in the past two years and percentage of adults ages 65-75 who reported receiving colorectal cancer screening within the recommended time period
Percentage of females ages 65-74 with an annual household income of $150,000 or more who reported receiving a mammogram in the past two years and percentage of adults ages 65-75 with an annual household income of $150,000 or more who reported receiving colorectal cancer screening within the recommended time period
93.7% - 90.6%
90.5% - 89.6%
89.5% - 86.6%
86.5% - 83.5%
83.4% - 72.4%
No Data
US Value: 76.8%
Top State(s): Rhode Island: 85.0%
Bottom State(s): Wyoming: 65.0%
Definition: Percentage of females ages 65-74 who reported receiving a mammogram in the past two years and percentage of adults ages 65-75 who reported receiving colorectal cancer screening within the recommended time period
Data Source and Years(s): U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Behavioral Risk Factor Surveillance System, 2024
Suggested Citation: America's Health Rankings analysis of U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Behavioral Risk Factor Surveillance System, United Health Foundation, AmericasHealthRankings.org, accessed 2026.
Cancer has been one of the top two leading causes of death in the United States for more than 75 years. Older adults have the highest incidence of cancer — in 2025, 88% of cancer diagnoses occurred among adults age 50 and older. Breast and colorectal cancers are most commonly diagnosed between the ages of 65 and 74.
Screening for cancer can help detect cancer early, when treatment is easiest and most effective. Breast cancer screening (mammograms) and colorectal cancer screening have saved many lives and are important methods for preventing cancer deaths. Both mammography and colorectal cancer screening are cost-effective compared with no screening.
Factors that can impact cancer screening rates among certain populations disproportionately include screening costs, health insurance status, access to health care facilities and sociodemographic differences.
According to America’s Health Rankings analysis, the prevalence of receiving the recommended number of breast and colorectal cancer screenings is higher among:
The United States Preventive Services Task Force recommends that all women age 40 and older receive a mammogram every two years. For women age 75 and older, current evidence is insufficient to determine if the benefits of mammography outweigh the harms.
Routine colorectal cancer screening is also recommended for all adults ages 50-75; for adults older than 75, it is an individual choice to be discussed with a doctor.
The Centers for Disease Control and Prevention recommends interventions that simplify the health care navigation process and expand accessibility and availability of care to address structural barriers. Evidence-based approaches include:
Healthy People 2030 has several objectives regarding cancer screenings, including increasing the proportion of women who get screened for breast cancer and increasing the proportion of adults who get screened for colorectal cancer.
Cancer Facts & Figures 2025. Atlanta, GA: American Cancer Society, 2025. https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2025/2025-cancer-facts-and-figures-acs.pdf.
Jayasekera, Jinani, and Jeanne S. Mandelblatt. “Systematic Review of the Cost Effectiveness of Breast Cancer Prevention, Screening, and Treatment Interventions.” Journal of Clinical Oncology 38, no. 4 (February 1, 2020): 332–50. https://doi.org/10.1200/JCO.19.01525.
Joung, Rachel Hae-Soo, Timothy W. Mullett, Scott H. Kurtzman, Sarah Shafir, James B. Harris, Katharine A. Yao, Karl Y. Bilimoria, et al. “Evaluation of a National Quality Improvement Collaborative for Improving Cancer Screening.” JAMA Network Open 5, no. 11 (November 16, 2022): e2242354. https://doi.org/10.1001/jamanetworkopen.2022.42354.
Khalili, Farhad, Behzad Najafi, Fariborz Mansour-Ghanaei, Mahmood Yousefi, Hadi Abdollahzad, and Ali Motlagh. “Cost-Effectiveness Analysis of Colorectal Cancer Screening: A Systematic Review.” Risk Management and Healthcare Policy Volume 13 (September 2020): 1499–1512. https://doi.org/10.2147/RMHP.S262171.
Ma, Zhen-Qiang, and Lisa C. Richardson. “Cancer Screening Prevalence and Associated Factors Among US Adults.” Preventing Chronic Disease 19 (April 21, 2022): 220063.https://doi.org/10.5888/pcd19.220063.
America’s Health Rankings builds on the work of the United Health Foundation to draw attention to public health and better understand the health of various populations. Our platform provides relevant information that policymakers, public health officials, advocates and leaders can use to effect change in their communities.
We have developed detailed analyses on the health of key populations in the country, including women and children, seniors and those who have served in the U.S. Armed Forces, in addition to a deep dive into health disparities across the country.
